µÚÎå½² ·Ö×ÓÉúÎïѧÑо¿·¨
)p](*Z^ Ò»¡¢ ÖØ×éDNA¼¼Êõ·¢Õ¹Ê·ÉϵÄÖØ´óʼþ
~a)20 1.40Äê´úÈ·¶¨ÁËÒÅ´«ÐÅÏ¢µÄЯ´øÕߣ¬¼´»ùÒòµÄ·Ö×ÓÔØÌåÊÇDNA¶ø²»Êǵ°°×ÖÊ£¬½â¾öÁËÒÅ´«µÄÎïÖÊ»ù´¡ÎÊÌ⣻
*g.,[a0 2.50Äê´úÌáʾÁËDNA·Ö×ÓµÄË«ÂÝÐý½á¹¹Ä£ÐÍºÍ°ë ±£Áô¸´ÖÆ»úÖÆ,½â¾öÁË»ùÒòµÄ×ÔÎÒ¸´ÖƺÍÊÀ´ú½»ÌæÎÊÌ⣻
|EU08b]P29 3.50Äê´úÄ©ÖÁ60Äê´ú£¬Ïà¼ÌÌá³öÁË"ÖÐÐÄ·¨Ôò"ºÍ²Ù×Ý×Óѧ˵,³É¹¦µØÆÆÒëÁËÒÅ´«ÃÜÂ룬³ä·ÖÈÏʶÁËÒÅ´«ÐÅÏ¢µÄÁ÷¶¯ºÍ±í´ï¡£
cl8Mv Äê·Ý ÊÂ ¼þ
l
sxii-#O 1869 F MiescherÊ״δÓÀ³ÒðºÓöÙÓ㾫×ÓÖзÖÀëDNA¡£
9{&x-ugM 1944 O.T. Avery֤ʵDNAÊÇÒÅ´«ÎïÖÊ¡£
.^W0;ISX 1952 A.D. HersheyºÍM.ChaseÔÙ´Î֤ʵºÍÊɾúÌåµÄÒÅ´«ÎïÖÊÊÇDNA¡£
@}}1xP4Sr
1953 J.D.WatsonºÍF.H.C.CrickÌá³öDNA·Ö×ӽṹµÄË«ÂÝÐýÄ£ÐÍ¡£M.WilkinsÓÃX-ÉäÏßÑÜÉ䷨֤ʵÁËÕâÒ»½á¹¹¡£
R|yTUGY 1957 A.Kornberg´Ó´ó³¦¸Ë¾úÖз¢ÏÖÁËDNA¾ÛºÏøI¡£
c9K\K~bk 1958 M. MeselsonºÍF. W. StahlÌá³öÁËDNAµÄ°ë±£Áô¸´ÖÆÄ£ÐÍ¡£
'a9.JS[pj 1959-1960 S. Ochoa·¢ÏÖRNA¾ÛºÏøºÍÐÅʹRNA£¬²¢Ö¤Ã÷mRNA¾ö¶¨Á˵°°×ÖÊ·Ö×ÓÖеݱ»ùËáÐòÁС£
Cu5
- w 1961 NirenbergÆÆÒëÁ˵ÚÒ»ÏàÒÅ´«ÃÜÂ룻F. JacobºÍJ. MonodÌá³öÁ˵÷½Ú»ùÒò±í´ïµÄ²Ù×Ý×ÓÄ£ÐÍ¡£
";%1sK 1964 C. YanofskyºÍS. BrennerµÈÈËÖ¤Ã÷£¬¶àëÄÁ´Éϵݱ»ùËáÐòÁÐÓë¸Ã»ùÒòÖеĺËÜÕËáÐòÁдæÔÚ׏²ÏßÐÔ¹Øϵ¡£
;0WlvK
F 1965 S. W. HolleyÍê³ÉÁ˽Íĸ±û°±ËátRNAµÄÈ«ÐòÁвⶨ£»¿Æѧ¼ÒÖ¤Ã÷ϸ¾úµÄ¿¹Ò©ÐÔͨ³£ÓÉ"ÖÊÁ£"DNAËù¾ö¶¨¡£
3*L,48wX 1966 M.W.Nirenberg£¬S.Ochoa¡¢H.G.Khorana¡¢F.H.C.CrickµÈÈËÆÆÒëÁËÈ«²¿ÒÅ´«ÃÜÂë¡£
7wiu%zfa:= 1970 H.O.Smith£¬K.W.WilcoxºÍT.J.Kelley·ÖÀëÁ˵ÚÒ»ÖÖÏÞÖÆÐÔºËËáÄÚÇÐø¡£H.M.TeminºÍD.Baltimore´ÓRNAÖ×Áö²¡¶¾Öз¢ÏÖ·´×ªÂ¼Ã¸¡£
AS398L 1972-1973 H.Boyer£¬P.BergµÈÈË·¢Õ¹ÁËDNAÖØ×é¼¼Êõ£¬ÓÚ72Äê»ñµÃµÚÒ»¸öÖØ×éDNA·Ö×Ó£¬73ÄêÍê³ÉµÚÒ»Àýϸ¾ú»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¡£
?/ g(Y 1975-1977 F.SangerÓëA.Maxam¡¢W.GilbertµÈÈË·¢Ã÷ÁËDNAÐòÁвⶨ¼¼Êõ¡£1977ÄêÍê³ÉÁËÈ«³¤5387bpµÄÊɾúÌå¦Õ174»ùÒò×é²â¶¨¡£
tp0*W
_<4 1978 Ê×´ÎÔڴ󳦸˾úÖÐÉú²úÓÉÈ˹¤ºÏ³É»ùÒò±í´ïµÄÈËÄÔ¼¤ËغÍÈËÒȵºËØ¡£
IrK )N 1980 ÃÀ¹úÁª°î×î¸ß·¨Ôº²Ã¶¨Î¢ÉúÎï»ùÒò¹¤³Ì¿ÉÒÔרÀû»¯¡£
' 1IH^<b 1981 R. D. PalmiterºÍR. L. Brinster»ñµÃ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: Article Search.asp?Field="Title&ClassID=&keyword=%D7%AA%BB%F9%D2%F2&Submit=+%CB%D1%CB%F7+¡¯" bbioo.com>ת»ùÒòСÊó£»A. C. SpradlingºÍG. M. RubinµÃµ½<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: Article Search.asp?Field="Title&ClassID=&keyword=%D7%AA%BB%F9%D2%F2&Submit=+%CB%D1%CB%F7+¡¯" bbioo.com>ת»ùÒò¹ûÓ¬¡£
)o CF|
2qc 1982 ÃÀ¡¢Ó¢Åú׼ʹÓõÚÒ»Àý»ùÒò¹¤³ÌÒ©Îï--ÒȵºËØ£»SangerµÈÈËÍê³ÉÁËÈëÊɾúÌå48,502bpÈ«ÐòÁвⶨ¡£
uDUSR+E> 1983 »ñµÃµÚÒ»Àý<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: Article Search.asp?Field="Title&ClassID=&keyword=%D7%AA%BB%F9%D2%F2&Submit=+%CB%D1%CB%F7+¡¯" bbioo.com>ת»ùÒòÖ²Îï¡£
$~l:l[Zs 1984 ˹̹¸£´óѧ»ñµÃ¹ØÓÚÖØ×éDNAµÄרÀû¡£
*0tNun 5=3 1986 GMOÊ×´ÎÔÚ»·¾³ÖÐÊÍ·Å¡£
fz\Az- 1988 J. D. Watson³öÈÎ"ÈËÀà»ùÒò×é¼Æ»®"Ê×ϯ¿Æѧ¼Ò¡£
:2+:(^l 1989 DuPont¹«Ë¾»ñµÃתÖ×Áö»ùÒòСÑõ--"Oncomouse"¡£
NH!!.Z" 1992 Å·¹²Ìå35¸öʵÑéÊÒÁªºÏÍê³É½ÍĸµÚÈýȾɫÌåÈ«ÐòÁвⶨ(315kb)
A1@a:P= 1994 µÚÒ»Åú»ùÒò¹¤³ÌÎ÷ºìÊÁÔÚÃÀ¹úÉÏÊС£
7KLq-u-8
1996 Íê³ÉÁ˽Íĸ»ùÒò×é(1.25¡Á107bp)È«ÐòÁвⶨ¡£
a7R7Ks|q 1997 Ó¢¹ú°®¶¡±¤ÂÞ˹ÁÖÑо¿Ëù»ñµÃ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡Ñò¡£
_,QUH" »ùÒò¹¤³ÌÖг£¼ûµÄÃû´Ê:
2oRmro ÒÅ´«¹¤³Ì--genetic engineering£¬»ùÒò²Ù×÷--gone manipulation£¬»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡--gone cloning£¬
QS_xOQ
' ÖØ×éDNA¼¼Êõ--recombinant DNA technology£¬·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡--molecular cloning¡£
!cZIoz »ùÒò¹¤³ÌµÄÖ÷ÒªÄÚÈÝ»ò²½Öè:
iQQJ` 1. ´ÓÉúÎïÓлúÌå»ùÒò×éÖУ¬·ÖÀë³ö´øÓÐÄ¿µÄ»ùÒòµÄDNAƬ¶Î¡£
Yp$lc^)c> 2. ½«´øÓÐÄ¿µÄ»ùÒòµÄÍâÔ´DNAƬ¶ÎÁ¬½Óµ½Äܹ»×ÔÎÒ¸´ÖƵIJ¢¾ßÓÐÑ¡Ôñ¼ÇºÅµÄÔØÌå·Ö×ÓÉÏ£¬ÐγÉÖØ×éDNA·Ö×Ó¡£
od>.5{o 3. ½«ÖØ×éDNA·Ö×ÓתÒƵ½Êʵ±µÄÊÜÌåϸ°û£¨Òà³Æ¼ÄÖ÷ϸ°û£©²¢ÓëÖ®Ò»ÆðÔöÖ³¡£
G9
TUU.T
4. ´Ó´óÁ¿µÄϸ°û·±Ö³ÈºÌåÖУ¬É¸Ñ¡³ö»ñµÃÁËÖØ×éDNA·Ö×ÓµÄÊÜÌåϸ°û£¬²¢É¸Ñ¡³öÒѾµÃµ½À©ÔöµÄÄ¿µÄ»ùÒò¡£
K} @q+ 5. ½«Ä¿µÄ»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½±í´ïÔØÌåÉÏ£¬µ¼Èë¼ÄÖ÷ϸ°û£¬Ê¹Ö®ÔÚеÄÒÅ´«±³¾°ÏÂʵÏÖ¹¦Äܱí´ï£¬²úÉú³öÈËÀàËùÐèÒªµÄÎïÖÊ¡£
"|H0 X# NoT oLt\ ¶þ¡¢ »ùÒò²Ù×÷µÄÖ÷Òª¼¼ÊõÔÀí
}T@AoIR0t 1£® ºËËáµÄÄý½ºµçÓ¾(Agarose & Polyacrylamide)
o<;"+ @v ½«Ä³ÖÖ·Ö×ӷŵ½Ìض¨µÄµç³¡ÖУ¬Ëü¾Í»áÒÔÒ»¶¨µÄËÙ¶ÈÏòÊʵ±µÄµç¼«Òƶ¯¡£Ä³ÎïÖÊÔڵ糡×÷ÓÃϵÄǨÒÆËٶȽÐ×÷µçÓ¾µÄËÙÂÊ£¬ËüÓëµç³¡Ç¿¶È³ÉÕý±È£¬Óë¸Ã·Ö×ÓËùЯ´øµÄ¾»µçºÉÊý³ÉÕý±È£¬¶øÓë·Ö×ÓµÄÄ¥²ÁϵÊý³É·´±È£¨·Ö×Ó´óС¡¢¼«ÐÔ¡¢½éÖʵÄÕ³¶ÈϵÊýµÈ£©¡£
Qoc-ZC"<6 ÔÚÉúÀíÌõ¼þÏ£¬ºËËá·Ö×ÓÖеÄÁ×Ëá»ùÍÅÊÇÀë×Ó»¯µÄ£¬ËùÒÔ£¬DNAºÍRNAʵ¼ÊÉϳʶà¾ÛÒõÀë×Ó״̬£¨Polyanions£©¡£½«DNA¡¢RNA·Åµ½µç³¡ÖУ¬Ëü¾Í»áÓɸº¼«¡úÕý¼«Òƶ¯¡£
uQ}kq7g
d ÔÚÄý½ºµçÓ¾ÖУ¬Ò»°ã¼ÓÈëä廯ÒÒ¶§£¨EB£©--ethidium bromideȾɫ£¬´Ëʱ£¬ºËËá·Ö×ÓÔÚ×ÏÍâ¹âÏ·¢³öÓ«¹â£¬ÈâÑÛÄÜ¿´µ½Ô¼50ng DNAËùÐγɵÄÌõ´ø¡£
/T0|<r!c DNAµÄÂö³åµçÓ¾¼¼Êõ :PFGE-Pulse-field gel electrophoresis
ftbu:RtK^^ 2£® ºËËáµÄ·Ö×ÓÔÓ½»¼¼Êõ
te_D
, ÔÚ´ó¶àÊýºËËáÔÓ½»·´Ó¦ÖУ¬¾¹ýÄý½ºµçÓ¾ ·ÖÀëµÄDNA»òRNA·Ö×Ó£¬¶¼ÊÇÔÚÔÓ½»Ö®Ç°£¬Í¨¹ýëϸ¹Ü×÷Óûòµçµ¼×÷Óð´ÆäÔÚÄý½ºÖеÄλÖÃÔ·â²»¶¯µØ"ÎüÓ¡" תÒƵ½ÂËĤÉϵġ£³£ÓõÄÂËĤÓÐÄáÁúÂËĤ¡¢ÏõËáÏËάËØÂËĤ£¬µþµª±½Ñõ¼×»ùÏËάËØÂËÖ½£¨DBM£©ºÍ¶þÒÒ°±»ùÒÒ»ùÏËάËØÂËĤ£¨DEAE£©µÈ¡£
H
Zc;.jJ ºËËá·Ö×ÓÔÓ½»ÊµÑé°üÀ¨ÈçÏÂÁ½¸ö²½Ö裺
_[V
6s#Wk3 ½«ºËËáÑùƷתÒƵ½¹ÌÌåÖ§³ÖÎïÂËĤÉÏ£¬Õâ¸ö¹ý³ÌÌسÆΪºËËáÓ¡¼£(nucleic acid blotting)תÒÆ£¬Ö÷ÒªÓеçÓ¾Äý½ººËËáÓ¡¼£·¨¡¢°ßµãºÍÏÁÏßÓ¡¼£·¨(dot and slot blotting)¡¢¾úÂäºÍÊɾú°ßÓ¡¼£·¨(colony and plaque blotting)£»
sSxra!tv4 ½«¾ßÓкËËáÓ¡¼£µÄÂËĤͬ´øÓзÅÉäÐÔ±ê¼Ç»òÆäËü±ê¼ÇµÄDNA»òRNA̽Õë½øÐÐÔÓ½»¡£ËùÒÔÓÐʱҲ³ÆÕâÀàºËËáÔÓ½»ÎªÓ¡¼£ÔÓ½»¡£
3i<*,@CY 3£® ϸ¾úµÄת»¯
V*)gJg Ëùνϸ¾úת»¯£¬ÊÇÖ¸Ò»ÖÖϸ¾ú¾úÖêÓÉÓÚ²¶»ñÁËÀ´×ÔÁíÒ»ÖÖϸ¾ú¾úÖêµÄDNA£¬¶øµ¼ÖÂÐÔ×´ÌØÕ÷·¢ÉúÒÅ´«¸Ä±äµÄÉúÃü¹ý³Ì¡£ÕâÖÖÌṩת»¯DNAµÄ¾úÖê½Ð×ö¹©Ìå¾úÖ꣬¶ø½ÓÊÜת»¯DNAµÄ¼ÄÖ÷¾úÖêÔò³Æ×öÊÜÌå¾úÖê¡£´ó³¦¸Ë¾úÊÇ×î¹ã·ºÊ¹ÓõÄʵÑé¾úÖê¡£ÔÚ¼ÓÈëת»¯DNA֮ǰ£¬±ØÐëÔ¤ÏÈÓÃCaCl2´¦Àí´ó³¦¸Ë¾úϸ°û£¬Ê¹Ö®³Ê¸ÐÊÜ̬£¨Competent Cells£©¡£Mg2+¶Ôά³ÖÍâÔ´DNAµÄÎȶ¨ÐÔÆðÖØÒª×÷Óã¬ÖÊÁ£DNAÖеĿ¹ÉúËØÊÇɸѡ±ê¼Ç¡£
o{/D:B ¶Ô¾ø´ó¶àÊýhsdR-£¬hsdM-Í»±äÌå¾úÖ꣨k12£©£¬Ã¿ug DNA¿ÉµÃ107-108¸öת»¯×Ó¡£
Ec|#i 4£® DNAÐòÁзÖÎö
d] {^ a. SangerµÄË«ÍÑÑõÁ´ÖÕÖ¹·¨
b=sc2)3? CambridgeµÄF. SangerÔÚ1977Äê·¢Ã÷ÓÃË«ÍÑÑõÁ´ÖÕÖ¹·¨²â¶¨µ¥Á´DNAµÄÐòÁУ¬Æä»ù±¾ÔÀíÈçÏ£º
>:.Bn 8- ¢ÙDNA¾ÛºÏøÄܹ»Óõ¥Á´DNA×÷Ϊģ°å£¬ºÏ³É׼ȷµÄDNA»¥²¹Á´£»¢Ú¸ÃøÄܹ»ÓÃ2¡¯£¬3¡¯--Ë«ÍÑÑõºËÜÕÈýÁ×Ëá×÷µ×Îï²¢½«Æä¾ÛºÏµ½ÐÂÉú¹ÑºËÜÕËáÁ´µÄ3¡¯-Ä©¶Ë£¬´Ó¶øÖÕÖ¹ÆäÑÓÉì·´Ó¦¡£ÔÚDNA²âÐò·´Ó¦ÖУ¬¼ÓÈëÄ£°åDNA£¬ÒýÎÌØÒìÐÔÒýÎÈçT7£¬T3£¬M13µÈ£©£¬DNA¾ÛºÏø£¬dA£¬dT£¬dG£¬dCºÍÒ»ÖÖddNTP¡£³£ÓÃKlenow´óƬ¶Î£¬ÎÞ5¡¯¡ú3¡¯ÍâÇÐø»îÐÔ¡£
5_PD?lg b£® Maxam-Gilbert»¯Ñ§ÐÞÊη¨(¹þ·ð´óѧ)
Y0DBkg ¸Ã·½·¨µÄ»ù±¾ÔÀíÊÇÓû¯Ñ§ÊÔ¼Á´¦Àí¾ßÓÐÄ©¶Ë·ÅÉäÐÔ±ê¼ÇµÄDNAƬ¶Î£¬Ôì³É¼î»ùµÄÌØÒìÐÔÇи²úÉúÒ»×é¾ßÓв»Í¬³¤¶ÈµÄDNAÁ´½µ½â²úÎ¾Äý½ºµçÓ¾·ÖÀëºÍ·ÅÉä×ÔÏÔÓ°Ö®ºó£¬¿ÉÖ±½Ó¶Á³ö´ý²âDNAƬ¶ÎµÄºËÜÕËáÐòÁС£
s;L7
_.hH@ ¸Ã·´Ó¦µÄ¹Ø¼üÔÚÓÚʹDNAµÄ4ÖÖºËÜÕËáÖУ¬Ö»ÓÐ1-2ÖÖ·¢ÉúÌØÒìÐԵĻ¯Ñ§ÇиӦ£º
16AYB17 ¼î»ùµÄÌØÒìÐÔÐÞÊΣ»
3;&N3:,X ±»ÐÞÊεļî»ù´ÓºËÌÇ»·ÉÏתÒÆ£»
dS-l2 $n ʧȥ¼î»ùµÄÌÇ»·²¿Î»·¢ÉúDNAÁ´¶ÏÁÑ¡£
sXAXHZ{ רÃÅÓÃÀ´¶ÔºËÜÕËá×÷»¯Ñ§ÐÞÊΣ¬²¢´ò¶ÏÁ×Ëá¶þõ¥¼üµÄ»¯Ñ§ÊÔ¼ÁÓÐÁòËá¶þ¼×õ¥(dimethylsulphate)ºÍëÂ(hydrazine)¡£
Y|Z*|c.4OK ÁòËá¶þ¼×õ¥ÊǼîÐÔ»¯Ñ§ÊÔ¼Á£¬ÄÜʹDNAÁ´ÖÐÄñàÑßʵÄN7ºÍÏÙàÑßʵÄN6λ·¢Éú¼×»ù»¯£¬ÔÚÖÐÐÔPH»·¾³ÖоÍÄÜʹÌÇÜÕ¼ü·¢ÉúË®½â£¬²¢ÒýÆðDNAÁ´µÄ¶ÏÁÑ¡£ÔÚ¼îÐÔÌõ¼þÏ£¬ëÂÄÜÌØÒìÐÔÇиîCºÍT¡£Èç¹û¼ÓÈë1 mol/LµÄNacl£¬ÄÇô£¬Ö»ÓÐC±»ÌØÒìÐÔÇи
Pm-@ZZ~ c£® DNAÐòÁзÖÎö×Ô¶¯»¯
3a =KgOvp ÓÃËļ׻ùÈôµ¤Ã÷(Tetramethylrhodamine)×÷Ϊӫ¹â¼Á±ê¼ÇDNAÒýÎ´øÓÐÕâÖÖÒýÎïµÄDNAƬ¶ÎÄÜÔÚ¼¤¹âÓÕµ¼Ï·¢³öÓ«¹â¡£°´ÕÕ±ê×¼µÄË«ÍÑÑõÖÕÖ¹·¨»ò»¯Ñ§ÖÕÖ¹·¨½øÐвâÐò·´Ó¦£¬ÅÜDNAÄý½ººóÓüÆËã»ú¼ì²â¡£
>zhbOkR9c d.DNAÔÓ½»²âÐò·¨(SBH-Sequencing by hybridization)
arnu|paw Èç¹ûÒ»¶Î½Ï¶ÌµÄDNA̽ÕëÄÜÓë½Ï³¤µÄDNAƬ¶ÎÔÓ½»£¬²¢ÐγÉÍêÈ«µÄË«Á´½á¹¹£¬ÎÒÃǾÍÍƲâÔÚ°ÐDNAÉÏ´æÔÚ×ÅÏàÓ¦µÄ»¥²¹ÐòÁУ¬Õâ¾ÍÊÇDNAÔÓ½»²âÐò·¨µÄ»ù±¾ÔÀí¡£Èç¹û½«Ò»ÖÖ12-merµÄ°ÐDNAÓëÍêÈ«Ëæ»úºÏ³ÉµÄ8-mer¹ÑºËÜÕËá¿ØÕë»ìºÏÔÓ½»£¬ÔÚ×ÜÊýΪ48=65536ÖÖ8-merµÄ¿ØÕëȺÌåÖУ¬½öÓÐ5ÖÖ̽Õë»áÓë°ÐDNAÔÓ½»£¬ÐγÉÍêÈ«»¥²¹µÄË«Á´·Ö×Ó¡£
0HE@L_$;2 µ±°ÐDNAÓë±ê¼Ç̽ÕëÐγÉG-T»òG-AÄ©¶Ë¼î»ù´íÅäµÄË«Á´Ìåʱ£¬¼ì²âÓÐÒ»¶¨ÄѶȡ£¹ÑºËÜÕËá̽ÕëÔ½¶Ì£¬¼î»ù´íÅäÔì³ÉµÄÈ¥Îȶ¨Ð§Ó¦Ô½Ã÷ÏÔ£¬½ÏÒ×ÓëÍêÈ«µÄË«Á´Ìå·Ö×ÓÏàÇø·Ö¡£µ«ÊÇ£¬Ì½Õë¶Ì£¬ÔÓ½»²úÎïµÄ×ÜÌåÎȶ¨ÐÔϽµ£¬ÐÅ/Ôë±ÈϽµ£¬Ó°Ïì½á¹ûµÄ¿É¿¿ÐÔ¡£ËùÒÔ£¬6-mer¹ÑºËÜÕËá¾ØÕóоƬֻÄÜÓÃÓڲⶨ500bpµÄ°ÐDNA£»7-mer=2000bp£¬8-mer=8000bp¡£
t6j|q nfw SBHµÄÓ¦Óãº
s iC/k* ¢Ù ¿ÉÓÐЧ¼ì²â°ÐDNAÖеĵ¥¼î»ùÍ»±ä£»
RszqDm ¢Ú ¿ÉÓÃÓÚ²»Í¬DNAƬ¶ÎÖ®¼äµÄÐòÁбȽϣ»
(sZB- ¢Û ¿ÉÓÃÓÚ¼ì²â²»Í¬Éú³¤·¢Óý״̬ÏÂϸ°ûÖÐÌض¨»ùÒòµÄ±í´ï×´¿ö£»
`6'fX[j5 ¢Ü ¿ÉÓÃÓÚ¼ìÑ鴫ͳ²âÐò¼¼ÊõµÄ׼ȷÐÔ¡£
Q\}5q3 m)&2zV/Q 5£® »ùÒòµÄ¶¨µãÓձ䣨site-directed mutagenesis£©
U:p<pTnMR ʹÒÑ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡»ùÒò»òDNAƬ¶ÎÖеÄÈκÎÒ»¸öÌض¨¼î»ù·¢ÉúÈ¡´ú¡¢²åÈë»òȱʧ±ä»¯µÄ¹ý³Ì½Ð×÷»ùÒòµÄ¶¨µãÓձ䣬ÊÇ»ùÒò¹¤³ÌºÍµ°°×Öʹ¤³ÌµÄÖØÒªÊֶΡ£
qWdL|8 a. ºÐʽÓÕ±ä(cassette mutagenesis)£¬°üÀ¨ºÐʽȡ´úÓÕ±äºÍ»ìºÏ¹ÑºËÜÕËáÓÕ±äÁ½ÖÖ·½Ê½¡£
/S%{`F= b£®¹ÑºËÜÕËáÒýÎïÓÕ±ä
Y*0mC "n} Ó¦Óû¯Ñ§ºÏ³ÉµÄº¬ÓÐÍ»±ä¼î»ùµÄ¹ÑºËÜÕËá¶ÌƬ¶Î×öÒýÎ½øÐÐDNA¸´ÖÆ£¬Ê¹¹ÑºËÜÕËáÒýÎï³ÉΪкϳɵÄDNA×ÓÁ´µÄÒ»¸ö²¿·Ö¡£
(Zp'|hx8o C£®PCRGÓëPCRÓÕ±ä
YajUdpJi =*fOej>G 6£® ÀûÓÃDNAÓëµ°°×ÖʵÄÏ໥×÷ÓýøÐкËËáÑо¿.
W2s6!_AN a.Äý½ºÖÍ»ºÊµÑé(Gel retardation assay)£¬ÓÖ³ÆDNAǨÒÆÂʱ仯ÊÔÑé(DNA mobility shift assay--EMSA)¡£
40+~;20 b£® DNase I Ó¡¼£ÊÔÑ飨DNase I foot printing£©
f/aSqhAW Ö÷Òª²½Ö裺
xwq {0jY ¢Ù ÓÃ32P±ê¼ÇDNAË«Á´Ä©¶Ë£¬²¢ÓÃREÇÐÈ¥Ò»¶Ë£»
En
yx+]9 ¢Ú ¼ÓÈëϸ°ûÌض¨ÖÜÆÚµ°°×ÖÊÌáÈ¡ÎÎÂÓý£»
v="i0lL_ ¢Û ¼ÓÈëÊÊÁ¿DNaseI»òÁòËá¶þ¼×õ¥-ÁùÇâßÁण¬Ê¹DNAÁ´·¢Éú¶ÏÁÑ¡£
N
vY%sx, ÕâÒ»·´Ó¦ÖУ¬DNaseI»òÁòËá¶þ¼×õ¥µÄÓÃÁ¿·Ç³£¹Ø¼ü£¬Òª±£Ö¤Ò»ÌõÁ´Ö»·¢ÉúÒ»´Î¶ÏÁÑ£¡
26?yEd6^Z ¢Ü³ÁµíDNA£¨°üÀ¨ÓëDNAÏà½áºÏµÄµ°°×ÖÊ£©£»
@
-)jU! ¢Ý½øÐÐDNAÄý½º·ÖÎö¡£
sk6C/
'0: Èç¹ûij¸öµ°°×ÖÊÒѾÓëDNAµÄÌض¨Çø¶ÎÏà½áºÏ£¬ÄÇô£¬Ëü¾Í»á±£Ö¤¸ÃÇø¶ÎDNAÃâÊÜÏû»¯»ò½µ½â×÷Óá£ÔÚµçÓ¾Äý½ºµÄ·ÅÉä×ÔÏÔӰͼƬÉÏ£¬ÏàÓ¦ÓÚµ°°×ÖʽáºÏµÄ²¿Î»²»²úÉú·ÅÉäÐÔ±ê¼ÇµÄÌõ´ø¡£
ly9.2<oz}L c£® ¼×»ù»¯¸ÉÈÅÊÔÑé(Methylation interference assay)
N$i!25F` ÓÃDMS´¦Àí°ÐDNA£¬Ê¹Æ½¾ùÿÌõÁ´ÉÏÖ»ÓÐÒ»¸öG±»¼×»ù»¯¡£½«¾Ö²¿¼×»ù»¯µÄDNAÓ뺬DNA½áºÏµ°°×µÄϸ°ûÌáÈ¡Îï¹²ÎÂÓýºó½øÐÐÄý½ºÖÍ»ºÊÔÑé¡£·ÖÀë¸÷ÖÖDNAÌõ´ø£¬²¢ÓÃÁùÇâßÁà¤Çиî¼×»ù»¯µÄ²Ð»ù¡£Èç¹ûÒòij¸öG²Ð»ùµÄ¼×»ù»¯×÷Óöø×èÖ¹Á˵°°×ÖÊÓëDNAµÄ½áºÏ£¬ÄÇô£¬ÁùÇâßÁशÔÕâ¸ö¼×»ù»¯G²Ð»ùµÄÇиî×÷Ó㬾ÍÖ»ÄÜÔÚûÓе°°×ÖʽáºÏµÄDNAÖй۲쵽¡£
')zdI]@M d£® ÌåÄÚ×ã¼£ÊÔÑé
c"~+Y2]tL ÓÃÊÊÁ¿DMS´¦ÀíÍêÕûµÄÓÎÀëϸ°û£¬Ê¹È¾É«ÖÊÖеÄG²Ð»ù¼×»ù»¯£¬ÌáÈ¡DNA²¢¼ÓÈëÁùÇâßÁà¤ÇиîDNAÁ´¡£Óë¶ÔÕÕµÄÂã¶DNA¾¼×»ù»¯´¦ÀíºóÐγɵÄÌݶÈÏà¶ÔÕÕ£¬¾ÍÄÜ·¢ÏÖDNAÁ´Éϵĵ°°×ÖʽáºÏÇø¡£
HJ~0_n& e'Njl?>3 Èý¡¢·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¼¼Êõ
yy8h8{=g 1¡¢¸ßÖÊÁ¿mRNAµÄÖƱ¸
}f45>@uMW Ó¦ÓÃPromega PolyAT tract mRNA Isolation System·ÖÀëPoly(A)RNA¡£½«Biotinylated Oligo(dT)ÒýÎïÓëϸ°û×ÜRNA¹²ÎÂÓý£¬¼ÓÈëÓë΢´ÅÇòÏàÁ¬µÄStreptavidin£¬Óôų¡Îü¸½ÓëPMPÏàÁ¬µÄSA-Biotinylated Oligo(dT)-mRNA¡£
2[zFKK 2£® ·´×ªÂ¼³ÉcDNA
#l2KJ7AMK ¿ÉͬʱÔÚ·´×ªÂ¼ÏµÍ³ÖмÓÈëOligo£¨dT£©12-18-mer¼°Ëæ»úÒýÎïR6£¬ÒÔ±£Ö¤µÃµ½È«³¤cDNA£»
:@K1pAh 4 ӦѡÓûîÐԽϸߵķ´×ªÂ¼Ã¸£¨Reverse transcriptase£©£»
WTK )SKa,. ӦѡÓü׻ù»¯dCTP£»
Mwm9{1{ Ó¦±£Ö¤Ëù»ñµÃË«Á´cDNAµÄ·½ÏòÐÔ¡£
d|I?%LX0p Super Script Choice cDNAºÏ³ÉϵͳÖÐËùÓõÄpoly£¨dT£©ÒýÎï
<u`m4w ÒòΪ¾ø´ó¶àÊý´ó³¦¸Ë¾úϸ°û¶¼»áÇгý´øÓÐ5¡¯-methyl CµÄÍâÔ´DNA£¬ËùÒÔ£¬Ó¦Ñ¡ÓÃmcrA- mcrB-¾úÖê¡£
F)XO5CBK 3£®·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µÄÖ÷Òª·½·¨
apmZ&Ab £¨1£©¹¹½¨cDNA¡¢ºËDNAÎĿ⣬ӦÓÃÏÖÓкËËá̽Õë·ÖÀëеÄÄ¿µÄ»ùÒò£»
d^pzMaCI £¨2£©²îʽÔÓ½»(differential screen)ºÍ¿Û³ýÔÓ½»(subtractive hybridization)¼¼Êõ£»
rs`"Kz`( £¨3£©DD-RT-PCR·¨¼°²î±ðÏÔʾ¼¼Êõ£»
LlbRr.wL £¨4£©²î±ð·ÖÎö·¨ (RDA·¨£¬¼´Representational difference analysis£©£»
jxeZ,w o £¨5£©½Íĸ˫ÔÓ½»ÌåϵTwo-hybrid system£»
n06T6oc £¨6£©Í¼Î»<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡·¨£¨map-based cloning£©ÓëȾɫÌå²½ÒÆ £*****enomic DNA Walking£©¡£
z"D'rHxy Ï°¹ßÉÏ£¬ÈËÃÇÓÃ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡±íʾÓÉͬһÎïÖÖ¾ßÓÐÏàͬ»ùÒòÐ͵ÄÁ½¸ö»ò¶à¸ö¸öÌå×é³ÉµÄȺÌå¡£ËùÒÔ£¬´ÓͬһÊܾ«ÂÑ·ÖÁѶøÀ´µÄµ¥ÂÑË«Éú×Ó£¨monozygotic twins£©±ãÊôÓÚͬһ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¡£Ï¸°ûѧÉÏ£¬<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡ÊÇÖ¸ÓÉͬһ¸ö×æϸ°û£¨progenitor cell£©·ÖÁѶøÀ´µÄ¾ßÓÐͬһÒÅ´«±³¾°µÄ×Óϸ°ûȺÌå¡£·Ö×ÓÉúÎïѧÉÏ£¬°Ñ½«ÍâÔ´DNA²åÈë¾ßÓÐ×ÔÖ÷¸´ÖÆÄÜÁ¦µÄÔØÌåDNAÖУ¬Ê¹Ö®µÃÒÔ×ÔÖ÷¸´ÖƺÍÓÀ¾Ã±£´æµÄ¹ý³Ì½Ð×ö·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¡£
a\_?zi]s&, ÎÄ¿âɸѡÓë»ùÒò·á¶ÈÓйء£¸ß·á¶È»ùÒò£¬Èç²ÏË¿Ðĵ°°×£¬ÂÑÇåµ°°×µÈÔÚijЩÌض¨×éÖ¯ÖпÉռϸ°û×ÜmRNAÁ¿µÄ50-90%£¬·Ç³£ÈÝÒ×±»·ÖÀë¡£µÍ·á¶È»ùÒò£¬Ò»°ãÔÚϸ°ûÖÐÖ»ÓÐ10-20¸ö¿½±´£¬²¸È鶯Îïϸ°ûÖпɺ¬10,000µ½40,000ÖÖ²»Í¬µÄmRNA£¬Èç¹ûÒª´ïµ½99%µÄÆÚÍûÖµ£¬´óÔ¼ÐèҪɸѡ150,000-170,000¸ö<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡×Ó¡£Ò»°ãÇé¿öÏ£¬Ã¿Î¢¿ËcDNA¿É²úÉú10Íò-60Íò¸ö<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡×Ó¡£
{zha jY7 A.²îʽÔÓ½»»ò¿Û³ýÔÓ½»<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¼¼Êõ
|
6/ # H* B.cRNA²îʽÏÔʾ·¨
$OGTHJ
A ³ýÁ˼«ÉÙÊýÌØÀý(Èç×éµ°°×»ùÒò)Ö®Í⣬¼¸ºõËùÓеÄÕæºË»ùÒòmRNA·Ö×ÓµÄ3¡¯-Ä©¶Ë£¬¶¼´øÓÐÒ»¶Î¶à¾ÛµÄÏÙÜÕËá½á¹¹£¬¼´Í¨³£Ëù˵µÄpoly(A)β°Í¡£
`
b$u w P.LiangµÈÈËÉè¼ÆºÏ³ÉÁËÈ«²¿12ÖÖ²»Í¬µÄÒýÎÓÃÒÔ·´×ªÂ¼mRNA£¬ºÏ³ÉµÚÒ»Á´cDNA¡£ÕâÖÖÒýÎïͨ³£½Ð×÷3¡¯-¶Ë궨ÍÑÑõºËÜÕËáÒýÎ²¢ÓÃ5¡¯-T11MN»ò5¡¯-T12MNͨʽ±íʾ¡£ÆäÖÐMΪ³ýÁËTÒÔÍâµÄÈκÎÒ»ÖÖºËÜÕËᣨ¼´A¡¢G»òC£©£¬¶øNÔòΪÈκÎÒ»ÖÖºËÜÕËᣨ¼´A¡¢G¡¢C»òT£©£¬¹ÊMN¹²ÓÐ12ÖÖ²»Í¬µÄÅÅÁÐ×éºÏ·½Ê½¡£
#" &<^
DDRT-PCRµÄÖ÷Òª²½Ö裺
zfGS=@e]G ¢ñ.´Ó²»Í¬·¢Óý½×¶Î»ò²»Í¬»ùÒòÐ͵Äϸ°ûȺÌåÖзÖÀëmRNA£¬²¢ÒÔ3¡¯Ãª¶¨ÒýÎï×÷Ϊ·´×ªÂ¼µÄÒýÎºÏ³ÉµÚÒ»¼ücDNA£»
ip)gI&kN`z ¢ò.ÓÃ5¡¯Ëæ»úÒýÎïºÍij¸ö3¡¯¶Ë궨ÒýÎï¶ÔÀ©ÔöµÚÒ»Á´(²ôÈë32p-dNTP)£»
mssCnr;
¢ó.ÓÃDNA±äÐÔ²âÐò½º·ÖÀëÀ©Ôö²úÎX¹âƬÆعâºó¼ì²â²î±ðÌõ´ø£»
3]MSS\uB ¢ô.»ØÊÕÌØÒìÐÔ²î±ðÌõ´ø£»
n.L/Xp
@gc ¢õ.ÓÃͬһÒýÎï¶ÔÀ©ÔöÒÑ»ØÊÕµÄDNAÌõ´ø£»
tMbracm ¢ö.ÓÃNorthern£¬Southern¼°²âÐò·¨·ÖÎöËùµÃµÄÌõ´ø£»
a|Yry ¢÷.ÒÔ¸ÃDNAƬ¶Î×ö̽Õ룬ɸѡȫ³¤cDNA»òºË»ùÒò¡£
J!+)v C.cDNA²îʽ·ÖÎö·¨(Representational ditterence analysis)
M?[~_0_J RDA·¨³ä·Ö·¢»ÓÁËPCRÒÔÖ¸ÊýÐÎʽÀ©ÔöË«Á´DNAÄ£°åµÄÌØÐÔ£¬Í¨¹ý½µµÍcDNAȺÌ帴ÔÓÐԺ͸ü»»cDNAÁ½¶Ë½ÓÍ·µÈ·½·¨£¬ÌØÒìÀ©ÔöÁËÄ¿µÄ»ùÒòƬ¶Î¡£ÒòΪÊÔÑé¶ÔÏó£¨Tester£©ºÍ¹©ÊÔ̽Õ루Driver£©ÔÚ½ÓÊܲîʽ·ÖÎöÇ°¾ù¾Ò»¸ö4¼î»ùÇиîø´¦Àí£¬ÐγÉƽ¾ù³¤¶È256bpµÄ´ú±íȺ£¨representation£©±£Ö¤¾ø´ó²¿·ÖÒÅ´«ÐÅÏ¢Äܱ»À©Ôö¡£Ã¿´ÎT¼õD·´Ó¦ºó½öÉèÖÃ72¡æ¸´ÐÔÓëÑÓÉ죬94¡æ¸´ÐÔÕâÁ½¸ö²ÎÊý¹²20¸öPCRÑ»·£¬PCR²úÎïµÄÌØÒìÐÔºÍËùµÃ̽ÕëµÄ´¿¶È·Ç³£¸ß¡£
RvXK?mL4F D.½Íĸ˫ÔÓ½»Ìåϵ
JnodDH ? Two-hybrid systemÒ²½Ðinteraction trap£¨Ï໥×÷ÓÃÏݾ®£©£¬ÊÇ90Äê´ú³õ·¢Õ¹ÆðÀ´µÄ·ÖÀë»ùÒòµÄз½·¨£¬¿ÉÓÃÓÚ·ÖÀëÄÜÓëÒÑÖª°Ðµ°°×ÖÊ£¨target protein£©Ï໥×÷ÓõĻùÒò¡£
J
n~t>? »ù±¾ÔÀí£º
)Up'W
ÕæºËÉúÎïµÄת¼Òò×Ó´ó¶àÊÇÓÉÁ½¸ö½á¹¹ÉÏ·Ö¿ª¡¢¹¦ÄÜÉ϶ÀÁ¢µÄ½á¹¹Óò×é³ÉµÄ¡£ÈçGAL4µÄN¶Ë1-147aaÊÇDNA½áºÏÓò£¨BD£©£¬ÆäC¶Ë768-881aaÊÇת¼¼¤»îÓò£¨AD£©¡£Ò»°ãÇé¿öÏ£¬ADÄÜÓëGAL4ЧӦ»ùÒòÆô¶¯×ÓÉÏÓεÄÌض¨DNAÇø¶Î£¨UAS£©Ïà½áºÏ£¬¶ø´Ëʱ£¬ADÔòÍƶ¯ÁËת¼Æðʼ¡£
f?Am) ÈôÓûùÒò¹¤³ÌµÄ·½·¨£¬½«GAL4 ADºÍBD·Ö±ð<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½²»Í¬µÄÔØÌåÉÏ£¬µ¼Èëͬһϸ°ûÖêÖбí´ï£¬Ð§Ó¦»ùÒòÎÞ·¨±»¼¤»î,µ«¿É°ÑÀ´×Ô²»Í¬×ªÂ¼Òò×ÓµÄAD»òBDÇøÓòÁ¬³ÉÒ»¸ö¹¦ÄÜ»ùÒò¡£
%Eq4>o?D Ö÷ҪʵÑé¹ý³Ì£º
,RXfJh
a. Ñ¡ÔñȱʧGAL4±àÂë»ùÒòµÄ½Íĸ¼ÄÖ÷¾úÖê-SFY526»òHF7c£»
F<9S, b. ¹¹½¨´øÓÐGAL1 UAS-Æô¶¯×Ó-lac Z£¨His3£©µÄת»¯ÔØÌå;
: *g3PhNE c. °ÑÒÑÖªµÄ°Ðµ°°×ÖʱàÂë»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½pGBT9µÄ¶à<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡λµãÉÏ£¬°ÑËùÓÐcDNA¶¼<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½pGAD424ÔØÌåÉÏ£¬¹¹³ÉcDNA±í´ïÎÄ¿â¡£
0YsBAfRG d. ´Ó´ó³¦¸Ë¾úÖзֱðÌáÈ¡ÕâÁ½ÖÖÖØ×éÖÊÁ£DNA£¬¹²×ª»¯¸ÐÊÜ̬Äð¾Æ½Íĸ¾úÖê¡£
SI"y&[iw e. ½«¹²×ª»¯µÄ½Íĸ¾úÖêÍ¿²¼ÓÚȱÉÙLeu£¬TrpºÍHisµÄÅàÑø»ùÉÏ£¬É¸Ñ¡±í´ïÏ໥×÷ÓõÄÔÓÖÖµ°°×µÄÑôÐÔ¾úÂä¡£
jT:z#B% E.»ùÒòµÄͼλ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡·¨
S!oG|%VuB# Map-based cloningÊÇ·ÖÀëδ֪ÐÔ×´Ä¿µÄ»ùÒòµÄÒ»Öֺ÷½·¨¡£´ÓÀíÂÛÉÏ˵£¬ËùÓоßÓÐijÖÖ±íÏÖÐ͵ĻùÒò¶¼¿ÉÒÔͨ¹ý¸Ã·½·¨<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µÃµ½¡£Ê×ÏÈ£¬½«Ä¿µÄ»ùÒò¶¨Î»µ½Ä³¸öȾɫÌåµÄÌض¨Î»µã£¬²¢ÔÚÆäÁ½²àÈ·¶¨½ôÃÜÁ¬ËøµÄRFLP»òRAPD·Ö×Ó±ê¼Ç¡£¶þ¡¢ÀûÓÃÓëÄ¿µÄ»ùÒò×î½ôÃÜÁ¬ËøµÄÒ»¶Ô·Ö×Ó±ê¼Ç×÷̽Õ룬ͨ¹ýȾɫÌå²½ÒƼ¼Êõ½«Î»ÓÚÕâÁ½¸ö±ê¼ÇÖ®¼äµÄ»ùÒòƬ¶Î<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP:
www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡²¢·ÖÀë³öÀ´¡£Èý¡¢¸ù¾Ý»ùÒò¹¦ÄÜ»¥×÷ÔÀí¼ø¶¨Ä¿µÄ»ùÒò¡£
]ucz8(' ͨ¹ý¶ÔÐí¶à²»Í¬µÄÉú̬Ðͼ°´óÁ¿ÏÞÖÆÐÔÄÚÇÐøºÍÔÓ½»Ì½ÕëµÄ·ÖÎö£¬ÕÒ³öÓëÄ¿µÄ»ùÒò¾àÀë×î½üµÄRFLP±ê¼Ç¡£ÔÚRFLP×÷ͼÖУ¬Á¬Ëø¾àÀëÊǸù¾ÝÖØ×éÂÊÀ´¼ÆËãµÄ£¬1cm£¨ÀåÃ×£©Ï൱ÓÚ1%µÄÖØ×éÂÊ¡£ÈËÀà»ùÒò×éÖУ¬1cm¡Ö1000kb;ÄâÄϽæ²ËÖУ¬1cm¡Ö290kb;СÂóÖУ¬ 1cm¡Ö3500kb¡£
kZU
v/]Y. {3H)c^Q ËÄ¡¢ DNAµÄMicroarray
m ,|)$R Ö»ÒªÊÂÏȳýÈ¥¸ß¶È¼°ÖеÈÖظ´ÐòÁУ¬ÈκÎDNA¶¼¿ÉÒÔ±»ÓÃÓÚMicroarray¡£×î¼òµ¥µÄÀý×ÓÊÇÓûúеÊְѼ«Î¢Á¿£¨nanoliters£©µÄDNAµãµ½²£Æ¬»òÆäËüÔØÌåÉÏ£¬ÕÕÉäUV lightʹ֮ÓÀ¾Ã¹Ì¶¨£¬Óò»Í¬Ï¸°ûÖÜÆÚ·¢Óý½×¶ÎµÄcDNA×÷̽ÕëϵͳÐÔµØÑо¿Ï¸°ûÖÐÈÎÒâʱÆÚÌØÒì±í´ïµÄ»ùÒò£»Èô°ÑijһÉúÎïÌåÄÚÈ«²¿È«²¿ÒÑÖª»ùÒò·Ö±ðµãµ½DNA΢ÁÐÕó»òÕß»ùÒòоƬÉÏ£¬ÔÙÓò»Í¬·¢Óý½×¶ÎµÄcDNAÓëÖ®ÔÓ½»£¬¾ÍÄÜÁ˽âijЩ»ùÒò¶ÔÌض¨Éú³¤·¢Óý½×¶ÎµÄÖØÒªÐÔ£»»ùÒòоƬ»¹¿ÉÓÃÓÚ½øÐлùÒòÕï¶Ï£¬¿É½¨Á¢Õý³£ÈËÌض¨×éÖ¯¡¢Æ÷¹ÙµÄ»ùÒòоƬ£¬¸ø³ö±ê×¼ÔÓ½»ÐźÅͼ¡£ÓÿÉÒɲ¡È˵ÄcDNA×ö̽ÕëÓëÖ®ÔÓ½»£¬¼ì²éÄÄЩ»ùÒòµÄ±í´ïÊÜÒÖÖÆ»ò¼¤»î¡£
{vf4l4J( 5J vrQGvL F?y4 L9|e |%HTBF 6 {j}Z*)m 9vL n#_ ---------------------------------------------------------------------------------------------
Li2-G j~;kh_ *=
;M',nx µÚÁù½² Ժ˻ùÒò±í´ïµ÷¿Ø
r!C#
PiT}I ÔºËÉúÎïºÍµ¥Ï¸°ûÕæºËÉúÎïÖ±½Ó±©Â¶ÔÚ±ä»ÃĪ²âµÄ»·¾³ÖУ¬Ê³Î﹩ӦºÁÎÞ±£ÕÏ£¬Ö»ÓÐÄܸù¾Ý»·¾³Ìõ¼þµÄ¸Ä±äºÏ³É¸÷ÖÖ²»Í¬µÄµ°°×ÖÊ£¬Ê¹´úл¹ý³ÌÊÊÓ¦»·¾³µÄ±ä»¯£¬²ÅÄÜά³Ö×ÔÉíµÄÉú´æºÍ·±ÑÜ¡£×ÔȻѡÔñÇãÏòÓÚ±£Áô¸ßЧÂʵÄÉúÃü¹ý³Ì¡£ÔÚÒ»¸öÿ30minÔöÖ³Ò»±¶µÄ109ϸ¾úȺÌåÖУ¬ÈôÓÐÒ»¸öϸ¾ú±ä³ÉÁË29.5minÔöÖ³Ò»±¶£¬´óÔ¼¾¹ý80ÌìµÄÁ¬ÐøÉú³¤ºó£¬Õâ¸öȺÌåÖеÄ99.9%¶¼½«¾ßÓÐ29.5minÔöÖ³Ò»±¶µÄÉú³¤Ëٶȡ£
`{v!|.d< r2 .f8U Ò»¸ö´ó³¦¸Ë¾úϸ°ûÖÐÔ¼ÓÐ2500-3000¸ö»ùÒò¡£¹À¼ÆÕý³£Çé¿öÏ£¬¿É´øÓÐ107¸öµ°°×ÖÊ£¬Æ½¾ùÿ¸ö»ùÒò²úÉú3000¶à¸öµ°°×ÖÊ·Ö×Ó¡£µ«´ó³¦¸Ë¾úÖÐÒ»°ã´øÓÐ15,000-30,000¸öºËÌÇÌ壬ÓÐ50ÓàÖÖºËÌÇÌå½áºÏµ°°×£¬ÊýÁ¿Ò²ºÜ¾ªÈË¡£´ËÍ⣬¸ºÔðÌǽͽâϵͳµÄµ°°×ÖÊÊýÁ¿Ò²ºÜ´ó¡£¶øÏó°ëÈéÌÇÜÕøµÈÓÕµ¼Ã¸£¬Æ京Á¿¿ÉÉÙÖÁÿϸ°û½ö1-5¸ö·Ö×Ó¡£
S#[w).7 ]hHL[hoFC Ò»¸öÌåϵÔÚÐèҪʱ±»´ò¿ª£¬²»ÐèҪʱ±»¹Ø±Õ¡£ÕâÖÖ"¿ª-¹Ø"£¨on-off£©»îÐÔÊÇͨ¹ýµ÷½Úת¼À´½¨Á¢µÄ£¬Ò²¾ÍÊÇ˵mRNAµÄºÏ³ÉÊÇ¿ÉÒÔ±»µ÷½ÚµÄ¡£µ±ÎÒÃÇ˵һ¸öϵͳ´¦ÓÚ"off"״̬ʱ£¬Ò²Óб¾µ×ˮƽµÄ»ùÒò±í´ï£¬³£³£ÊÇÿÊÀ´úÿ¸öϸ°ûÖ»ºÏ³É1»ò2¸ömRNA·Ö×Ó¡£Ëùν"¹Ø"ʵ¼ÊµÄÒâ˼ÊÇ»ùÒò±í´ïÁ¿ÌرðµÍ£¬ºÜÄÑÉõÖÁÎÞ·¨¼ì²â¡£
pf@H;QS` &CcUr#|
¿Æѧ¼Ò°ÑÕâ¸ö´ÓDNAµ½µ°°×ÖʵĹý³Ì³ÆΪ»ùÒò±í´ï(gene expression)£¬¶ÔÕâ¸ö¹ý³ÌµÄµ÷½Ú¾Í³ÆΪ»ùÒò±í´ïµ÷¿Ø(gene regulation»ògene control)¡£ÒªÁ˽⶯¡¢Ö²ÎïÉú³¤·¢ÓýµÄ¹æÂÉ¡¢ÐÎ̬½á¹¹ÌØÕ÷ºÍÉúÎïѧ¹¦ÄÜ£¬¾Í±ØÐëŪÇå³þ»ùÒò±í´ïµ÷¿ØµÄʱ¼äºÍ¿Õ¼ä¸ÅÄÕÆÎÕÁË»ùÒò±í´ïµ÷¿ØµÄÃØÃÜ£¬ÎÒÃÇÊÖÖоÍÓÐÁËÒ»°Ñ½ÒʾÉúÎïѧ°ÂÃîµÄ½ðÔ¿³×¡£
8x /]H(J ed\umQ] »ùÒò±í´ïµ÷¿ØÖ÷Òª±íÏÖÔÚÒÔϼ¸¸ö·½Ã棺
):5M + ¢Ù ת¼ˮƽÉϵĵ÷¿Ø(transcriptional regulation)£»
duT'$}2@> ¢Ú mRNA¼Ó¹¤³ÉÊìˮƽÉϵĵ÷¿Ø(differen, tial processing of RNA transcript)£»
S?BI)shmg ¢Û ·ÒëˮƽÉϵĵ÷¿Ø(differential translation of mRNA).
[!'fE#"a [19QpK WM ÔºËÉúÎïÖУ¬ÓªÑø×´¿ö(nutritionalstatus)ºÍ»·¾³ÒòËØ(environmental factor)¶Ô»ùÒò±í´ïÆðמÙ×ãÇáÖصÄÓ°Ïì¡£ÔÚÕæºËÉúÎïÓÈÆäÊǸߵÈÕæºËÉúÎïÖУ¬¼¤ËØˮƽ(hormone level)ºÍ·¢Óý½×¶Î(developmental stage)ÊÇ»ùÒò±í´ïµ÷¿ØµÄ×îÖ÷ÒªÊֶΣ¬ÓªÑøºÍ»·¾³ÒòËصÄÓ°ÏìÁ¦´óΪϽµ¡£
+`]AutNv u+_6V Ò»¡¢ ÈéÌDzÙ×Ý×ӵĵ÷¿Øģʽ
JQ"R%g`8 ´ó³¦¸Ë¾úÈéÌDzÙ×Ý×Ó(lactose operon)°üÀ¨3¸ö½á¹¹»ùÒò£ºZ¡¢YºÍA£¬ÒÔ¼°Æô¶¯×Ó¡¢¿ØÖÆ×ÓºÍ×è¶ô×ӵȡ£×ªÂ¼Ê±£¬RNA¾ÛºÏøÊ×ÏÈÓëÆô¶¯Çø(promoter,P)½áºÏ£¬Í¨¹ý²Ù×ÝÇø(operator,O)ÏòÓÒת¼¡£×ªÂ¼´ÓOÇøµÄÖм俪ʼ£¬°´Z¡úY¡úA·½Ïò½øÐУ¬Ã¿´Îת¼³öÀ´µÄÒ»ÌõmRNAÉ϶¼´øÓÐÕâ3¸ö»ùÒò¡£×ªÂ¼µÄµ÷¿ØÊÇÆô¶¯ÇøºÍ²Ù×ÝÇø½øÐеġ£
Z6\H4,k& X1Vj"4'wT Z±àÂë¦Â-°ëÈéÌÇÜÕø£»Y±àÂë¦Â-°ëÈéÌÇÜÕ͸¹ýø£»A±àÂë¦Â-°ëÈéÌÇÜÕÒÒõ£»ùתÒÆø¡£¦Â-°ëÈéÌÇÜÕøÊÇÒ»ÖÖ¦Â-°ëÈéÌÇÜÕ¼üµÄרһÐÔø£¬³ýÄܽ«ÈéÌÇË®½â³ÉÆÏÌÑÌǺͰëÈéÌÇÍ⣬»¹ÄÜË®½âÆäËû¦Â-°ëÈéÌÇÜÕ£¨Èç±½»ù°ëÈéÌÇÜÕ£©¡£¦Â-°ëÈéÌÇÜÕ͸¹ýøµÄ×÷ÓÃÊÇʹÍâ½çµÄ¦Â-°ëÈéÌÇÜÕ£¨ÈçÈéÌÇ£©ÄÜ͸¹ý´ó³¦¸Ë¾úϸ°û±ÚºÍÔÉúÖÊĤ½øÈëϸ°ûÄÚ¡£¦Â-°ëÈéÌÇÜÕÒÒõ£»ùתÒÆøµÄ×÷ÓÃÊÇ°ÑÒÒõ£¸¨Ã¸AÉϵÄÒÒõ£»ùתµ½¦Â-°ëÈéÌÇÜÕÉÏ£¬ÐγÉÒÒõ£°ëÈéÌÇ¡£
2^f6@;=M A.
wuB 1£® øµÄÓÕµ¼-lacÌåϵÊܵ÷¿ØµÄÖ¤¾Ý
W9M~2<
L ÔÚ²»º¬ÈéÌǼ°¦Â-°ëÈéÌÇÜÕµÄÅàÑø»ùÖУ¬lac+»ùÒòÐÍÿ¸ö´ó³¦¸Ë¹¦Ï¸°ûÄÚ´óÔ¼Ö»ÓÐ1-2¸öø·Ö×Ó¡£Èç¹ûÔÚÅàÑø»ùÖмÓÈëÈéÌÇ£¬Ã¸µÄŨ¶ÈºÜ¿ì´ïµ½Ï¸°û×ܵ°°×Á¿µÄ6%»ò7%£¬Ã¿¸öϸ°ûÖпÉÓг¬¹ý105¸öø·Ö×Ó¡£
-RKqbfmi= sO$X5S C9 ¿Æѧ¼Ò°Ñ´ó³¦¸Ë¾úϸ°û·ÅÔÚ¼ÓÓзÅÉäÐÔ35S±ê¼ÇµÄ°±»ùËᵫûÓÐÈκΰëÈéÌÇÓÕµ¼ÎïµÄÅàÑø»ùÖз±Ö³¼¸´ú£¬È»ºóÔÙ½«ÕâЩ´øÓзÅÉä»îÐÔµÄϸ¾úתÒƵ½²»º¬35S¡¢ÎÞ·ÅÉäÐÔµÄÅàÑø»ùÖУ¬Ëæ×ÅÅàÑø»ùÖÐÓÕµ¼ÎïµÄ¼ÓÈ룬¦Â-°ëÈéÌÇÜÕø±ã¿ªÊ¼ºÏ³É¡£·ÖÀë¦Â-°ëÈéÌÇÜÕø£¬·¢ÏÖÕâÖÖøÎÞ35S±ê¼Ç¡£ËµÃ÷øµÄºÏ³É²»ÊÇÓÉÇ°Ìåת»¯¶øÀ´µÄ£¬¶øÊǼÓÈëÓÕµ¼Îïºóкϳɵġ£
4Uzx2
QTLGM-
Z ÒѾ·ÖÀëÔÚÓÐÓÕµ¼Îï»òûÓÐÓÕµ¼ÎïµÄÇé¿ö϶¼ÄܲúÉúlacmRNAµÄÍ»±äÌ壬ÕâÖÖʧȥµ÷½ÚÄÜÁ¦µÄÍ»±äÌå³ÆΪÓÀ¾ÃÐÍÍ»±äÌ壬Ϊ·ÖÁ½ÀࣺIÐͺÍOÐÍ¡£
!U[/P6
+0 , SB5" IÐÍ£ºÒ°ÉúÐÍΪI+£¬Í»±äÐÍΪI-
Ax{C ^u OÐÍ£ºÒ°ÉúÐÍΪO+£¬Í»±äÐÍΪOc¡£
K}a3Bj, l)K8.(2 I+¡úI-»òO+¡úOcºó£¬Z¡¢Y¡¢A½á¹¹»ùÒò¾ù±íÏÖΪÓÀ¾Ã±í´ï£¬ËùÒÔI»ùÒò±»³ÆΪµ÷½Ú»ùÒò(regulatory gene)¡£Ñо¿·¢ÏÖ£¬I»ùÒòÊÇÒ»¸ö²úÉú×è¶ôÎïµÄµ÷½Ú»ùÒò£¬Æä²úÎïʹÌåϵ¹Ø±Õ¡£I-Í»±äÌåÓÉÓÚ²»ÄܲúÉú×è¶ôÎʹϸ°û³ÉΪlacÓÀ¾Ã±í´ïÐÍ¡£I-/I+¾Ö²¿¶þ±¶ÌåÓÉÓÚ´øÓÐÒ»¸öÕý³£×è¶ôÎʹϸ°ûÖеÄlacÈÔÈ»±»ÒÖÖÆ¡£
T6^H%;G [L`w nP ÒÅ´«Ñ§Í¼Æ×·ÖÎöÖ¸³ö£¬OcÍ»±äλÓÚIÓëZÖ®¼ä£¬ËùÒÔ£¬lacÌåϵµÄ4¸ö»ùÒòµÄÐòÁÐΪIOZY¡£Í¨¹ýÕâЩ¹Û²ì£¬JacobºÍMonodÍƶÏOcÍ»±ä´ú±íDNAÁ´ÉϵÄÒ»¸öλµã»òÒ»¸ö·Ç±àÂëÇøÓò£¬¶ø²»ÊÇÒ»¸ö»ùÒò£¬ÒòΪ¿É±àÂëµÄ»ùÒò¾ßÓл¥²¹ÐÔ£¬¶øOcûÓÐÕâÒ»ÌØÐÔ¡£O¾ö¶¨ÏàÁÚZ»ùÒòµÄ²úÎïÊÇÓÕµ¼Ðͺϳɻ¹ÊÇÓÀ¾ÃÐͺϳɣ¬OÇøÓò³ÆΪ²Ù×Ý»ùÒò¡£
J*nWCL +Jl
PQ~5 2. ²Ù×Ý×ÓÄ£ÐÍ
;w(tXcXZ JacobºÍMonodÈÏΪÓÕµ¼Ã¸£¨ËûÃǵ±Ê±³ÆΪÊÊӦø£©ÏÖÏóÊǸö»ùÒòµ÷¿ØÎÊÌ⣬¿ÉÒÔÓÃʵÑé·½·¨½øÐÐÑо¿£¬Òò´ËѡΪͻÆÆ¿Ú£¬ÖÕÓÚͨ¹ý´óÁ¿ÊµÑé, ¼°·ÖÎö£¬½¨Á¢Á˸òÙ×Ý×ӵĿØÖÆÄ£ÐÍ¡£
>HL$=J_K? hj+iB,8 ¢Ù Z¡¢Y¡¢A»ùÒòµÄ²úÎïÓÉͬһÌõ¶à˳·´×ÓµÄmRNA·Ö×ÓËù±àÂë¡£
kT1 2
¢Ú Õâ¸ömRNA·Ö×ÓµÄÆô¶¯×Ó½ô½Ó×ÅOÇø£¬¶øλÓÚIÓëOÖ®¼äµÄÆô¶¯×ÓÇø£¨P£©£¬²»Äܵ¥¶ÀÆ𶯺ϳɦÂ-°ëÈéÌÇÜÕøºÍ͸¹ýøµÄÉúÀí¹ý³Ì¡£
4Gor*{ ¢Û ²Ù×Ý»ùÒòÊÇDNAÉϵÄһС¶ÎÐòÁУ¨½öΪ26bp£©£¬ÊÇ×è¶ôÎïµÄ½áºÏλµã¡£
p{0NKyOvU ¢Üµ±×è¶ôÎïÓë²Ù×Ý»ùÒò½áºÏʱ£¬lacmRNAµÄת¼ÆðʼÊܵ½ÒÖÖÆ¡£
["N_t:9I ¢ÝÓÕµ¼Îïͨ¹ýÓë×è¶ôÎï½áºÏ£¬¸Ä±äËüµÄÈýά¹¹Ïó£¬Ê¹Ö®²»ÄÜÓë²Ù×Ý»ùÒò½áºÏ£¬´Ó¶ø¼¤·¢lacmRNAµÄºÏ³É¡£µ±ÓÐÓÕµ¼Îï´æÔÚʱ£¬²Ù×Ý»ùÒòÇøûÓб»×è¶ôÎïÕ¼¾Ý£¬ËùÒÔÆô¶¯×ÓÄܹ»Ë³ÀûÆðʼmRNAµÄºÏ³É¡£
LCMZw6p A(}D76o_ 3. Lac²Ù×Ý×ӵı¾µ×ˮƽ±í´ï
dBb
&sA-A ÒòΪÓÕµ¼ÎïÐèÒª´©¹ýϸ°ûĤ²ÅÄÜÓë×è¶ôÎï½áºÏ£¬¶øÔËתÓÕµ¼ÎïÐèҪ͸¹ýø¡£ÔÚ·ÇÓÕµ¼×´Ì¬ÏÂÓÐÉÙÁ¿£¨1-5¸ömRNA·Ö×Ó£©lac mRNAºÏ³É--±¾µ×ˮƽÓÀ¾ÃÐͺϳɡ£
H63?Erh>a 5Ei4$T 4. ÆÏÌÑÌǶÔlac²Ù×Ý×ÓµÄÓ°Ïì--´úлÎï×è¶ôЧӦ
tYUg%2G Ñо¿±íÃ÷£¬ÆÏÌÑÌǶÔlac²Ù×Ý×Ó±í´ïµÄÒÖÖÆ×÷ÓÃÊǼä½ÓµÄ£¬ÒòΪ´æÔÚÒ»Öִ󳦸˾úÍ»±äÖ꣬ËüÕý³£µÄÌǽͽâ¹ý³ÌÊÜ×裬ÆÏÌÑÌÇ-6-Á×Ëá²»ÄÜת»¯ÎªÏÂÒ»²½´úлÖмäÎ¸Ã¾úÖêÄÜÔÚÓÐÆÏÌÑÌÇ´æÔÚµÄÇé¿öϱ»ÓÕµ¼ºÏ³Élac mRNA¡£
uWDWf5@ U%V4@iz~\m 5. cAMPÓë´úлÎD»îµ°°×
M.u1SB0 µ±ÆÏÌÑÌǺÍÈéÌÇͬʱ´æÔÚÓÚÅàÑø»ùÖÐʱ£¬lacÆô¶¯×Ó±í´ïÊÜ×裬ûÓЦÂ-°ëÈéÌÇÜÕø»îÐÔ£»µ±ÆÏÌÑÌÇÏûºÄÍêÒÔºó£¨Í¼ÖмýÍ·´¦£©£¬Ï¸°ûÄÚcAMPŨ¶ÈÔö¼Ó£¬¦Â-°ëÈéÌÇÜÕø»îÐÔ±»ÓÕµ¼£¬Ò»¶ÈÍ£Ö¹Éú³¤µÄϸ°ûÓÖ»Ö¸´·ÖÁÑ¡£Èç¹û½«Ï¸¾ú·ÅÔÚȱ·¦Ì¼Ô´µÄÅàÑø»ùÖУ¬Ï¸°ûÄÚcAMPŨ¶È¾ÍºÜ¸ß£»ÈôÔÚº¬ÆÏÌÑÌǵÄÅàÑø»ùÖÐÅàÑø£¬Ï¸¾úÖеÄcAMPŨ¶È¾Í»áºÜµÍ£»Èç¹û½«Ï¸¾úÖÃÓÚ¸ÊÓÍ»òÈéÌǵȲ»½øÐÐÌǽͽâµÄ̼ԴÅàÑø»ùÖУ¬Ï¸¾úÖÐcAMPµÄŨ¶ÈÒ²»áºÜ¸ß¡£
##5e:<c&[ =HHtLW.|, Ñо¿Ö¤Êµ£¬ÆÏÌÑÌÇËùÒýÆðµÄ´úлÎïÒÖÖÆ(Catabolite repression)ÏÖÏóµÄʵÖÊÊǸôúлÎï½µµÍÁËϸ°ûÖÐcAMPµÄº¬Á¿.ÊÂʵÉÏ£¬cAMP-CAP¸´ºÏÎïÊÇlacÌåϵµÄpositive regulator£¬ËüÃDz»ÄÜ´úÌælacIºÍlacOµÄ¹¦ÄÜ(negative regulator)¡£
c0f8*O4i Dj9ecV
` cAMP-CAP²»µ«ÄÜÓëDNAÏà½áºÏ£¬Ôì³ÉË«ÂÝÐýÍäÇú£¬Ò×ÓÚÐγÉÈýԪת¼Æðʼ¸´ºÏÎËü»¹ÄÜÖ±½ÓÓ°ÏìRNA¾ÛºÏøµÄ»îÐÔ¡£Dominant negative£¨Trans-dominant£©lacI-d£¬Ö»ÒªÓÐÕâ¸ö"»·"µÄÑÇ»ù´æÔÚ£¬lacI+»ùÒò²úÎ×è¶ôÎÎÞ·¨ÓëOÇøÏà½áºÏlac operonµÃµ½±í´ï¡£
oZ\zi> Y, >41K>=K 6. lac²Ù×Ý×ÓDNAµÄµ÷¿ØÇøÓò--P.O.Çø
E++3GagdiD lac P£¨Æô¶¯×ÓÇø£©´ÓI»ùÒò½áÊøµ½mRNAת¼ÆðʼλµãÖ¹£¬¹²³¤82bp£¨-82¡«+1£©OÇø¾ÍÊÇ×è¶ôÎï½áºÏÇø£¬Î»ÓÚPÇøºó°ë²¿·ÖºÍת¼ÆðʼÇø£¨-7¡«+28£©£¬¸ÃÇøÐòÁÐÓжԳÆÐÔ£¬Æä¶Ô³ÆÖÐÐĵãÔÚ+11λ¡£PÇøµÄCAMP-CAP½áºÏÇø£¨-67¡«-52£©Ò²ÓжԳÆÐÔ£¬Æä¶Ô³ÆλµãÔÚ-60¡«-59Ö®¼ä¡£
`dJ?j[
P,p {xu~Dx ÔÚÒ»¸öÍêÈ«±»ÓÕµ¼µÄϸ°ûÖУ¬¦Â-°ëÈéÌÇÜÕø¡¢Í¸¹ýø¼°ÒÒõ£»ùתÒÆøµÄ¿½±´Êý±ÈÀýΪ1:0.5:0.2£¬Õâ¸ö±ÈÀýÔÚÒ»¶¨³Ì¶ÈÉÏ·´Ó³ÁËÒÔ¦Â-°ëÈéÌÇÜÕ×÷ΪΨһ̼Դʱϸ°ûµÄÐèÒª¡£²»Í¬µÄøÔÚÊýÁ¿ÉϵIJîÒìÊÇÓÉÓÚÔÚ·ÒëˮƽÉÏÊܵ½µ÷½ÚËùÖ¡£
'4)4* 3z, o-+H- ¢Ùlac mRNA¿ÉÄÜÓë·Òë¹ý³ÌÖеĺËÌÇÌåÏàÍÑÀ룬´Ó¶øÖÕÖ¹µ°°×ÖÊÁ´µÄ·Òë¡£ÕâÖÖÏÖÏó·¢ÉúµÄƵÂÊÈ¡¾öÓÚÿһ¸öºóÐøµÄAUGÃÜÂë×ÓÔÙ¶ÈÆðʼ·ÒëµÄ¸ÅÂÊ¡£
;MH_pE/m ¢ÚÔÚlac mRNA·Ö×ÓÄÚ²¿£¬A»ùÒò±ÈZ»ùÒò?
-7u_ \XFk (Qd@Q,@(s [p:3]